46 research outputs found
Number of deaths and cause-specific mortality rates per 100,000 py, by calendar year.
<p>Rates are standardised to the population distribution of adult men in the South African population <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0022807#pone.0022807-Statistics2" target="_blank">[12]</a></p>*<p>refers to average change per year in rate of cause-specific death.</p
Description of cohort.
1<p>Includes those who later died (n = 450), these men are counted in both the death and medically-boarded columns.</p>2<p>Predominantly transfers to another mine or unknown reasons.</p>3<p>Only available for 1312 (63%) patients.</p
Cause-specific mortality rates, by age group, and comparison to South African male population mortality rate in adult men aged over 15 years.
<p>Cause-specific mortality rates, by age group, and comparison to South African male population mortality rate in adult men aged over 15 years.</p
(Un)popular culture and citizenship - mapping illicit drug-using in Trainspotting
Design scenario for partner notification. This is an example of the scenarios used in the focus group discussions, and it involves a person (Sharon) and a narrative about her user journey with the application. (DOCX 13 kb
Additional file 1 of Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK
Appendix S1. A detailed overview of the key assumptions underpinning the epidemiological model employed in the paper. (PDF 70 kb
Cause of death by HIV status, time period, and enrolment in Wellness programme – number, rate/1000py, and proportion of deaths.
1<p>comprises 252 assaults, 73 suicides, 316 motor vehicle accidents, 143 mine accidents, 51 other accidents (such as drowning), 34 unspecified.</p>2<p>comprises 3 Cytomegalovirus, 6 nocardia, 18 interstitial pneumonitis, 3 fungal pneumonia, 2 viral pneumonia.</p>3<p>comprises 3 Candidiasis, 6 malaria, 2 aspergillus, 2 cysticercosis, 1 histoplasmosis, 1 toxoplasmosis, 29 septicaemia, 7 Hepatitis B Virus, 41 unspecified infection.</p>4<p>comprises 27 Kaposi’s sarcoma, 16 non-Hodgkin’s lymphoma, 6 lymphomas of unspecified type.</p>5<p>comprises 39 gastrointestinal disorders (such as appendicitis or gastric ulcer), 42 renal failures, 15 epilepsy or other neurological disease, 1 silicosis, 27 other respiratory diseases (such as asthma or COPD), 10 other medical causes.</p>*<p>n.o.s. = not otherwise specified.</p>**<p>includes all deaths in HIV positive people without any clearly non-HIV related cause of death.</p
Crude and age standardised mortality rates (all-cause) in cohort, by year, 95% error bars shown.
<p>Crude and age standardised mortality rates (all-cause) in cohort, by year, 95% error bars shown.</p
Additional file 2 of Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK
Appendix S2. Economic model assumptions. (PDF 40 kb
Additional file 12 of Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK
Table S8. Cases of disease for different vaccination strategies. (PDF 1254 kb
